SCHEMBL22025307

SCHEMBL22025307

CC(C)(O)C1CCC(OF)CC1

nearest known ligand 0.32

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
LMNA P02545 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL456619 0.79
SCHEMBL7526154 0.79 LMNA (0.42) LMNA
SCHEMBL16845906 0.78 LMNA (0.33) LMNA
SCHEMBL19987184 0.78 LMNA (0.33) LMNA
SCHEMBL19791203 0.76 LMNA (0.32) LMNA
SCHEMBL18032443 0.76 LMNA (0.32) LMNA
SCHEMBL16855784 0.74 HTT (0.37) LMNA
SCHEMBL17739256 0.73 EPHX1 (0.32) LMNA
SCHEMBL18959370 0.73 MEN1 (0.33) LMNA
SCHEMBL7513835 0.72

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3059238-B1 FUSED HETEROCYCLIC COMPOUND, PREPARATION METHOD THEREFOR, PHARMACEUTICAL COMPOSITION, AND USES THEREOF SHANGHAI YINGLI PHARM CO LTD (CN) 2020-05-27 EP disclosed